Geopolitics of AI

Business

Rigetti Computing Faces Headwinds: Key Quantum Chip Delay and DARPA Contract Snub Challenge Growth Trajectory

Rigetti Computing's roadmap hits a snag as it delays its next-generation 108-qubit processor to address error rates and fails to advance in a strategic DARPA program. The dual setbacks intensify scrutiny on the company's competitive position against well-funded rivals in the race for practical quantum computing.

Jan 30, 2026

Business

U.S. Bets on Rare Earths Diversity with $1.6 Billion Rival Backing, MP Materials Navigates New Policy Landscape

The U.S. government's $1.6 billion commitment to USA Rare Earth signals a strategic pivot towards fostering competition in the critical minerals sector, reducing price supports and introducing new volatility. As policy shifts, industry leader MP Materials counters with record production and expanded magnet manufacturing, highlighting the intensifying race to secure a domestic supply chain for EVs and defense.

Jan 30, 2026

Business

Insmed's Pivotal Moment: Upcoming TPIP Data and Analyst Spotlight Set Stage for Critical Investor Decisions

As Insmed prepares to unveil key data for its TPIP program at a major medical congress, fresh analyst coverage highlights the treatment's potential to reshape the company's future. Amidst a volatile stock performance, investors are weighing high-growth prospects against persistent financial risks.

Jan 30, 2026

Business

NewtekOne Posts Record 2025, Touts Bank Charter Success and Disruptive Tech Edge

NewtekOne (NASDAQ: NEWT) reported robust Q4 and full-year 2025 results, highlighting the third anniversary of its OCC-chartered bank. The financial holding company saw net income rise 16.4% to $80 million, driven by strong deposit growth, successful securitizations, and a focus on serving independent business owners with long-term, 'patient capital' loans.

Jan 30, 2026

US

Italian Protesters Target US Immigration Policy with Witty Anti-ICE Signs

Demonstrators in Italy have used humor and local cultural touchstones to craft pointed protests against US Immigration and Customs Enforcement (ICE) policies, blending food rules with political dissent.

Feb 3, 2026

Business

Sanctions and Legal Woes Push Russia's Crypto Mining Giant BitRiver to the Brink

Russia's premier cryptocurrency miner, BitRiver, faces insolvency proceedings as its CEO is placed under house arrest, marking a dramatic fall for a firm already crippled by international sanctions and mounting legal disputes.

Feb 2, 2026

Business

Disney's Iger: No Need for More IP Acquisitions Amid Warner Bros. Discovery Bidding War

Disney CEO Bob Iger says the fierce competition for Warner Bros. Discovery highlights the 'tremendous value' of Disney's existing franchises, while reaffirming the company's focus on organic IP creation over further major acquisitions.

Feb 2, 2026

Business

SAP Shifts Healthcare Strategy, Appoints New North America Chief Amid Market Scrutiny

SAP discontinues its legacy IS-H healthcare software in the DACH region, impacting dozens of hospitals, while appointing David Robinson to lead its crucial North American operations. The moves signal a strategic pivot as the enterprise software giant navigates a complex market landscape.

Jan 30, 2026

Business

Monarch Casinos Set to Report Q4 Earnings Amid Slowing Growth Forecast

Monarch Casinos & Resorts (MCRI) will release its fourth-quarter financial results after Wednesday's market close, with analysts projecting modest revenue growth but heightened scrutiny on its high-end gaming segment performance.

Feb 3, 2026

Business

Fox Corp. Set to Report Q4 Earnings Amid Flat Revenue Forecasts

Fox Corporation (NASDAQ: FOXA) is scheduled to release its fourth-quarter financial results Wednesday morning, with analysts anticipating steady revenue but slower growth compared to last year's surge.

Feb 3, 2026

Business

Boston Scientific Set to Report Q4 Earnings Amid High Expectations

Medical device giant Boston Scientific (BSX) is scheduled to release its fourth-quarter financial results before market open on Wednesday, with Wall Street anticipating continued strong revenue growth and another potential earnings beat.

Feb 3, 2026

Business

IDEX Earnings on Deck: Analysts Eye Modest Growth Amid Sector Momentum

Industrial manufacturer IDEX (IEX) is set to release its quarterly results Wednesday morning, with Wall Street anticipating a slight revenue increase. The report comes amid a broader rally in fluid and gas handling stocks.

Feb 3, 2026

Business

Nektar's Rezpeg Shows Promise Beyond Eczema, Fueling Bullish Outlook for Immunology Platform

New late-breaking data for Nektar Therapeutics' lead drug candidate, rezpegaldesleukin, suggests systemic anti-inflammatory benefits in patients with comorbid asthma, potentially expanding its market reach and strengthening the investment case for the biopharma firm.

Feb 3, 2026

Business

Abivax's Lead Drug Shows Promise in Refractory Ulcerative Colitis, Fueling Investor Optimism

French biotech Abivax sees renewed investor interest following strong Phase 3 data for its oral therapy obefazimod in hard-to-treat ulcerative colitis, with analysts pointing to a clear path to regulatory approval and significant market potential.

Feb 3, 2026

Business

Cronos Group Surges on U.S. Rescheduling Hopes: A Deep Dive into the Bull Case

Cronos Group's stock has rallied on renewed optimism for U.S. cannabis reform. We examine the regulatory shift, strategic positioning, and long-term potential driving investor sentiment.

Feb 3, 2026

Business

Venture Global: A High-Stakes Bet on LNG Growth Amid Legal Turmoil

Venture Global LNG, a polarizing leader in U.S. gas export infrastructure, trades at a deep discount despite record operational performance. This analysis explores the bull case for the stock, which hinges on resolving multibillion-dollar legal disputes and capitalizing on soaring global LNG demand.

Feb 3, 2026

Business

Shark Tank's Kevin O'Leary Champions 'Trump Accounts' as Antidote to National Financial Literacy Crisis

Investor and TV personality Kevin O'Leary has thrown his weight behind a proposed national child investment account policy, framing it as a bipartisan solution to America's widespread financial illiteracy and a foundational tool for building generational wealth.

Feb 3, 2026

Business

General Dynamics: Defense and Aerospace Giant Powers Ahead, But Valuation Questions Loom

Buoyed by a record defense backlog and a surging Gulfstream business, General Dynamics (GD) is generating robust cash flow. However, analysts debate whether its premium valuation already reflects this strong operational momentum, leaving new investors watching for a better entry point.

Feb 3, 2026

Business

ACADIA Pharmaceuticals: A Deep Value Play or a Value Trap?

After a significant rebound, ACADIA Pharmaceuticals (ACAD) shares present a conundrum for investors. While a discounted cash flow model suggests deep undervaluation, the stock's volatile history and mixed performance metrics demand a closer look at the underlying narrative.

Feb 3, 2026

Business

Amalgamated Financial: A Deep Value Play or a Market Mirage?

Amalgamated Financial (AMAL) shares have delivered stellar multi-year returns, but a closer look at valuation models suggests the stock may be significantly undervalued despite its strong run. We analyze the numbers behind the rally.

Feb 3, 2026